All terms in EFO
| Label | Id | Description |
|---|---|---|
| obsolete_bilateral striopallidodentate calcinosis | Orphanet_1980 | |
| lysophosphatidylethanolamine 18:2 measurement | EFO_0010369 | [The quantification of lysophosphatidylethanolamine 18:2 levels in a sample.] |
| lysophosphatidylethanolamine 16:0 measurement | EFO_0010366 | [The quantification of lysophosphatidylethanolamine 16:0 levels in a sample.] |
| hypophosphatasia | MONDO_0018570 | [Hypophosphatasia (HPP) is a rare heritable metabolic disorder characterized by defective mineralization of bone and/or teeth in the presence of reduced activity of unfractionated serum alkaline phosphatase (ALP). The clinical spectrum is extremely wide, from stillbirth at one end to fractures of the lower extremities in adulthood, at the other, or even no bone manifestations (odontohypophosphatasia).] |
| developmental anomaly of metabolic origin | MONDO_0015327 | |
| lysophosphatidylethanolamine 18:0 measurement | EFO_0010367 | [The quantification of lysophosphatidylethanolamine 18:0 levels in a sample.] |
| GM17119 | CLO_0014942 | [UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100] |
| 184-hTERT | EFO_0009375 | [Telomerase-immortalized human breast epithelial cell line.] |
| HMEC184 | EFO_0001190 | |
| lysophosphatidylcholine 20:5 measurement | EFO_0010364 | [The quantification of lysophosphatidylcholine 20:5 levels in a sample.] |
| GM17113 | CLO_0014943 | [HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 8 UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24] |
| lysophosphatidylcholine 22:6 measurement | EFO_0010365 | [The quantification of lysophosphatidylcholine 22:6 levels in a sample.] |
| lysophosphatidylcholine 20:3 measurement | EFO_0010362 | [The quantification of lysophosphatidylcholine 20:3 levels in a sample.] |
| GM17114 | CLO_0014945 | [HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 8] |
| lysophosphatidylcholine 20:4 measurement | EFO_0010363 | [The quantification of lysophosphatidylcholine 20:4 levels in a sample.] |
| lysophosphatidylcholine 18:1 measurement | EFO_0010360 | [The quantification of lysophosphatidylcholine 18:1 levels in a sample.] |
| obsolete_femoral-facial syndrome | Orphanet_1988 | |
| lysophosphatidylcholine 18:2 measurement | EFO_0010361 | [The quantification of lysophosphatidylcholine 18:2 levels in a sample.] |
| photoallergic dermatitis | MONDO_0006596 | [A delayed hypersensitivity involving the reaction between sunlight or other radiant energy source and a chemical substance to which the individual has been previously exposed and sensitized. It manifests as a papulovesicular, eczematous, or exudative dermatitis occurring chiefly on the light-exposed areas of the skin.] |
| allergic contact dermatitis | EFO_1000668 | [A contact dermititis that is an allergic skin reaction to foreign chemical or substances leading to red, itchy, weepy reaction where the skin has come into contact with a substance that the immune system recognizes as foreign., An inflammatory skin condition caused by an immune response to direct contact between the skin and an allergen. It consists of a delayed type of allergic reaction at the affected site with resulting red, swollen, and blistered skin that may itch or leak.] |